SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016414
Filing Date
2023-05-11
Accepted
2023-05-11 16:35:55
Documents
97
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1158047
2 ex10-1.htm EX-10.1 852922
3 ex10-2.htm EX-10.2 1238567
4 ex31-1.htm EX-31.1 19542
5 ex31-2.htm EX-31.2 19036
6 ex32-1.htm EX-32.1 9938
  Complete submission text file 0001493152-23-016414.txt   10360521

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE hrow-20230331.xsd EX-101.SCH 65881
8 XBRL CALCULATION FILE hrow-20230331_cal.xml EX-101.CAL 86419
9 XBRL DEFINITION FILE hrow-20230331_def.xml EX-101.DEF 339966
10 XBRL LABEL FILE hrow-20230331_lab.xml EX-101.LAB 505960
11 XBRL PRESENTATION FILE hrow-20230331_pre.xml EX-101.PRE 430644
91 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1281449
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 23911681
SIC: 2834 Pharmaceutical Preparations